Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: LastShadow who wrote (4883)	1/21/1998 11:24:00 PM
From: David Fitz	Read Replies (1) \| Respond to of 120523

Last Shadow, what do you think of ASND right now? Appreciate the advice.

To: LastShadow who wrote (4883)	1/22/1998 2:54:00 AM
From: Jenna	Read Replies (3) \| Respond to of 120523

What's sizzling in the Pharmaceutical and Health Care sectors? Best performers (besides FRX) reporting their earnings in the next three weeks are... January 27: ESCMF January 28: CNTO, January 30: VVUS, QTRN, MEDI February 3: HTDC, CPLY February 11: MLNM, February 12: CMD The companies above had earnings growth of 50% to 300% last quarter, and their current quarter are projected to increase. VVUS and CNTO, the very volatile of the group can be easily played as a daytrade or two day hold BEFORE earnings come out. Although their growth is projected to have been in 3 digits last quarter, they are still iffy and any disappointment might have dire consequences. I would play them ANY day from tomorrow until earnings as they will move with the entire pharmaceutical sector and even better the closer the earnings date. ____________________ QTRN is a fine play. It is a Contract Research Organization, a firm that manages clinical trials for small biotech companies that lack the staff, experience, or money to manage their clinical trials internally. QTRN is the largest CRO and it took in more than 200 million in revenue in the third quarter of 1997. ESCMF I've played for the past 4 quarters and it still has a 47% growth for the last quarter. __________________ HDTC and CMD are not as risky as CNTO and VVUS yet both are projected to gain in the three digit range. HDTC, CPLY, ESCMF are ranked in 90th percentile and above for insider buying. _______________________ CMD has just reached a new 52 week high on very high volume. It has a fundamental rank of 90 and an analyst rank of 98. _________________ All the above have had either moving average, Stochastic, Wilder, or MACD breakouts and have high relative strength and EPS rank. They have had either increased ERG, Accumulation/Distribution, Price Rank in the last week and are trending above their 10 day moving average..